Sort
21,281 grants matching “influenza”
Personal Respiratory Isolation System for Safe Transport and Treatment of Patients with Highly Transmissible Infectious Diseases
$986,477Sridhar Kota · Inspire Rx Llc · R44 · FY2025 · HL
Chicago Community-Acquired Pneumonia Consortium
$986,255Richard G Wunderink · Northwestern University At Chicago · U18 · FY2009 · IP
On demand blood tests for select agent diagnosis
$986,226David Alland · Rbhs-New Jersey Medical School · R01 · FY2013 · AI
Modeling the ecology of tissue-resident T cells
$986,013Andrew Yates · Columbia University Health Sciences · U01 · FY2020 · AI
Surveillance and Response to Avian /Pandemic Influenza
$986,000Katya Gamazina · Path · U51 · FY2006 · CI
Center for Computational Mass-Spectrometry
$985,859Pavel A Pevzner · University Of California, San Diego · P41 · FY2008 · RR
CENTER FOR COMPUTATIONAL MASS-SPECTROMETRY
$985,859Pavel A Pevzner · University Of California, San Diego · P41 · FY2008 · RR
Diagnostic Influenza RT-PCR Array
$985,553Darrell P Chandler · Akonni Biosystems, Inc. · R44 · FY2011 · AI
Does repeated influenza vaccination constrain influenza immune responses and protection?
$985,423Sheena G Sullivan · University Of Melbourne · R01 · FY2020 · AI
An RSV Prefusion F Vaccine that Overcomes Immunosenescence
$984,686Mark Yondola · Calder Biosciences, Inc. · R44 · FY2022 · AG
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
$984,405Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2024 · AI
Targeting the NS1 Protein for the Development of Influenza Virus Antivirals
$984,281Robert M Krug · University Of Texas At Austin · U01 · FY2007 · AI
ECOLOGY AND EVOLUTION OF AVIAN INFLUENZA
$984,169The Chancellor, Masters, And Scholars Of The University Of Cambridge · · FY2014 · Department of Defense
Structure and dynamics of RNA elements regulating viral aberrant RNA synthesis
$984,000Arend Jan Te Velthuis · Princeton University · DP2 · FY2025 · AI
A single antiviral to treat multiple opportunistic infections
$983,882Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2024 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$983,724Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
ULTRAFAST OPTICAL PROCESSES LABORATORY
$983,260Feng Gai · University Of Pennsylvania · P41 · FY2015 · GM
Therapeutic factor XI blockade for sepsis
$983,121Erik Ian Tucker · Aronora, Inc. · R44 · FY2014 · AI
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$983,087Mary N. Carrington · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$982,971Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2021 · GM
Antigen Presentation to Self-reactive T Cells in Human Autoimmune Diseases
$982,670Kai W Wucherpfennig · Dana-Farber Cancer Inst · P01 · FY2010 · AI
A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States
$982,580Sophia Koo · Brigham And Women'S Hospital · U01 · FY2023 · TR
Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant
$982,488Brenton Scott · Pulmotect, Inc · R44 · FY2015 · HL
Administrative Core
$981,320Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2014 · AI
Strain-Independent Therapeutic Antibodies for Influenza
$981,301Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2017 · AI